Adapted Hospital Discharge Intervention: the CONNECT Pilot
CONNECT
Communication Outreach for Navigation and Needs-based Care Transitions (CONNECT): A Pilot Randomized Controlled Trial
2 other identifiers
interventional
60
1 country
1
Brief Summary
Hospital discharge is a dangerous time for patients: one in five will suffer an adverse event, such as a medication error, and nearly 25% will be readmitted within 30 days. This time is even more dangerous for patients with who face communication barriers, including those with non-English language preference (NELP), low health literacy, and the elderly. The investigators will pilot a post-discharge educational intervention to reinforce written discharge instructions (known as the After Visit Summary or AVS) using a randomized controlled trial design (2:1 intervention: control). The control group will receive current standard of care discharge education which includes a nurse reviewing their AVS and an automated call in English that allows patients to numerically select types of problems/questions that are then escalated to a nurse who should return their call within a few days. The intervention group will receive the standard of care discharge education with the AVS and an additional post-discharge educational call delivered by a registered nurse or other qualified health professional with the option to have written instructions professionally translated and sent via MyChart message--if available in their preferred language.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 13, 2025
CompletedFirst Posted
Study publicly available on registry
June 24, 2025
CompletedStudy Start
First participant enrolled
January 16, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2027
January 20, 2026
January 1, 2026
1.1 years
June 13, 2025
January 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Retention success by linguistic group
Number of enrolled participants who completed all study assessments stratified by linguistic group.
12 months
Fidelity to the intervention
The number of scheduled educations calls that were completed for participants in the intervention arm based on nursing documentation in Epic.
12 months
Secondary Outcomes (3)
Acceptability of the intervention
12 months
Feasibility of the intervention
12 months
Patient Understanding of Discharge Instruction (UDI) Scale
12 months
Study Arms (2)
Educational intervention
OTHERParticipants randomized into this arm will receive current hospital discharge education and an additional post-discharge educational call.
Standard of care
NO INTERVENTIONParticipants randomized into this arm will receive current hospital discharge education.
Interventions
24-72 hours after hospital discharge, a nurse will call participants to review the written After Visit Summary (AVS) given at discharge, including primary diagnosis, self-care instructions, emergency plan, medication changes, how and why to take medication, and scheduled follow up. These phone calls will take on average 10-15 minutes.
Eligibility Criteria
You may qualify if:
- Registered language in Epic (written or spoken) is Spanish, Haitian Creole, Portuguese, Cape Verdean, or Vietnamese
- Admitted to medicine team at Boston Medical Center (BMC)
- Being discharged home (to the community)
You may not qualify if:
- On airborne infections precautions at time of recruitment
- On C diff precautions at time of recruitment
- On suicide precautions at time of recruitment
- Nurse report of participant displaying cognitive impairment, ongoing delirium, or aggression
- Discharge observed during a prior admission
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Boston Medical Center
Boston, Massachusetts, 02118, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Kirsten Austad, MD MPH
Boston Medical Center, Family Medicine
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 13, 2025
First Posted
June 24, 2025
Study Start
January 16, 2026
Primary Completion (Estimated)
March 1, 2027
Study Completion (Estimated)
March 1, 2027
Last Updated
January 20, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share